IMARC Group has recently released a report titled “Chronic Cough Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the chronic cough market size, latest trends, and growth forecast. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market scenario, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the chronic cough market.

Chronic cough is a respiratory tract disease in which cough lasts for a long period of eight weeks or sometimes much longer. The condition affects the upper airway of the respiratory system and leads to sleep interruptions and feelings of fatigue. The common symptoms of chronic cough include a runny or stuffy nose, shortness of breath, sore throat, hoarseness, wheezing sound while breathing, heartburn or a sour taste in the mouth, frequent throat clearing, persistent chest pain, coughing up blood, etc. The diagnosis of this disease involves the evaluation of the patient’s clinical features, medical history, physical examination, chest X-rays, CT scans, and bronchoscopy.

Request a Free Sample Report: https://www.imarcgroup.com/chronic-cough-market/requestsample

The growing cases of respiratory infections owing to high levels of air pollution, prolonged exposure to dust and chemical fumes, chain smoking, etc., are primarily driving the chronic cough market. In addition to this, the rising incidences of various associated risk factors, such as chronic bronchitis, asthma, gastroesophageal reflux disease, coronavirus infection, etc., are also augmenting the market growth.

Furthermore, the increasing adoption of the upper endoscopy procedure, which involves the utilization of a flexible, lighted instrument to monitor the stomach, esophagus, and small intestine and offer disease diagnosis, is acting as another significant growth-inducing factor. Besides this, the escalating application of effective medications, including antihistamines, bronchodilators, corticosteroids, decongestants, etc., to treat chronic cough by minimizing inflammation and opening the airways is creating a positive outlook for the market. Additionally, the growing popularity of over-the-counter cough suppressants, as they can help unclog a stuffy nose by clearing the mucus from the airway, is anticipated to propel the chronic cough market in the coming years.

Report Period:

  • Base Year: 2022
  • Historical Period: 2017-2022
  • Market Forecast: 2023-2033

Countries Included:

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the chronic cough market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the chronic cough market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/request?type=report&id=7341&flag=C

Key Questions Answered in this Report:

  • How has the chronic cough market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
  • What was the country-wise size of the chronic cough market across the seven major markets in 2022 and what will it look like in 2033?
  • What is the growth rate of the chronic cough market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?

Browse the Latest Research Report:

Bronchopulmonary Dysplasia Market Report 2023-2033

Bronchitis Market Report 2023-2033

Bladder Cancer Market Report 2023-2033

Bipolar Disorder Market Report 2023-2033

How This Report Can Help You:

  • The report on chronic cough market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the chronic cough market.
  • The chronic cough market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
  • Our report on the chronic cough market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800